Featured Post

Elon Musk’s Influence on the 2024 Presidential Election and Its Potential Outcomes

  In the upcoming 2024 U.S. presidential election, the influence of tech moguls like Elon Musk is a point of significant interest. Musk, with his vast following, has demonstrated an ability to sway public opinion through his business decisions, public statements, and presence on social media platforms like X (formerly Twitter). The effect Musk’s actions may have on the election—and candidates such as Donald Trump—is worth examining as he becomes a key player in the larger landscape of digital influence. Elon Musk and Digital Influence in Politics A Shift in Public Influence Musk’s reach extends beyond business; he is now a major influencer in political spheres. By acquiring X, Musk gained direct access to one of the most influential social media platforms in the world, where he regularly engages with a diverse audience. His unpredictable political stances and commentary resonate with millions, and his platform decisions have the potential to shape public opinion. Musk’s Public Poli...

WHO Conditionally Backs Covid-19 Vaccine Trials that Infect People

image


Controversial trials in which volunteers are intentionally infected with Covid-19 4 could accelerate vaccine development, according to the World Health Organization, which has released new guidance on how the approach could be ethically justified despite the potential dangers for participants. From a report:

So-called challenge trials are a mainstream approach in vaccine development and have been used in malaria, typhoid and flu, but there are treatments available for these diseases if a volunteer becomes severely ill. For Covid-19, a safe dose of the virus has not been established and there are no failsafe treatments if things go wrong. Scientists, however, increasingly agree that such trials should be considered, and the WHO is the latest body to indicate conditional support for the idea. “There’s this emerging consensus among everyone who has thought about this seriously,” said Prof Nir Eyal, the director of Rutgers University’s Center for Population-Level Bioethics in the US.

Comments